gliclazide has been researched along with adenosine diphosphate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Civardi, E; Dettori, AG; Megha, S; Pini, M; Ponari, O; Portioli, D | 1 |
| Dechavanne, M; Lagarde, M; Thouverez, JP; Verry, M | 1 |
| Isobe, J; Mizuno, A; Shima, K; Yano, M | 1 |
| Jackson, WP; Jacobs, P; Kernoff, L; Klaff, LJ; Vinik, AI | 1 |
| Arfors, KE; Bergqvist, D; Tangen, O | 1 |
| Ashcroft, FM; de Wet, H; Proks, P | 2 |
| Geddawy, A; Imamura, T; Okamura, T; Shimosato, T; Tawa, M | 1 |
1 review(s) available for gliclazide and adenosine diphosphate
| Article | Year |
|---|---|
Sulfonylureas and platelet function.
Topics: Adenosine Diphosphate; Blood Glucose; Blood Platelets; Collagen; Diabetes Mellitus; Diabetic Angiopathies; Epinephrine; Gliclazide; Glyburide; Humans; Platelet Aggregation; Sulfonylurea Compounds | 1981 |
7 other study(ies) available for gliclazide and adenosine diphosphate
| Article | Year |
|---|---|
Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.
Topics: Adenosine Diphosphate; Bleeding Time; Blood Glucose; Blood Platelets; Diabetes Mellitus; Gliclazide; Humans; Long-Term Care; Platelet Adhesiveness; Platelet Aggregation; Sulfonylurea Compounds | 1979 |
Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Cyclases; Aspirin; Carbon Radioisotopes; Collagen; Cyclic AMP; Dipyridamole; Gliclazide; Glucuronidase; Humans; Phosphoric Diester Hydrolases; Platelet Adhesiveness; Prostaglandins E; Serotonin; Sulfonylurea Compounds; Thrombin; Tritium | 1975 |
Inhibitory action of gliclazide on platelet functions.
Topics: Adenosine Diphosphate; Adult; Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cell Adhesion; Endothelium, Vascular; Epoprostenol; Gliclazide; Humans; In Vitro Techniques; Kinetics; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Sulfonylurea Compounds | 1989 |
Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
Topics: Adenosine Diphosphate; Animals; Collagen; Female; Gliclazide; Glipizide; Hemostasis; Humans; In Vitro Techniques; Lasers; Male; Microcirculation; Platelet Aggregation; Rabbits; Sulfonylurea Compounds; Tolbutamide | 1980 |
Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Diabetes Mellitus, Type 1; Gliclazide; Humans; Hypoglycemic Agents; Inhibitory Concentration 50; KATP Channels; Mice; Oocytes; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Rats; Sulfonylurea Receptors; Xenopus laevis | 2013 |
Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/SUR1 but not Kir6.2/SUR2A KATP channels: a mechanistic study.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amino Acid Motifs; Amino Acid Sequence; Animals; Binding Sites; Cells, Cultured; Gliclazide; Humans; Insulin-Secreting Cells; Ion Channel Gating; Molecular Sequence Data; Potassium Channels, Inwardly Rectifying; Protein Binding; Rats; Sulfonylurea Receptors; Xenopus | 2014 |
Mechanism underlying endothelium-dependent relaxation by 2-methylthio-ADP in monkey cerebral artery.
Topics: Adenosine Diphosphate; Animals; Apamin; Arachidonic Acids; Arginine; Biological Factors; Cerebral Arteries; Charybdotoxin; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Female; Glycyrrhetinic Acid; Macaca; Male; Nitric Oxide; Nitroprusside; Thionucleotides; Vasodilation | 2010 |